相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The mitochondrial cyclophilin D/p53 complexation mediates doxorubicin-induced non-apoptotic death of A549 lung cancer cells
Jia-huan Lu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Rapid-onset Apathy May Be the Only Clinical Manifestation After Dorsal Striatum Hemorrhagic Lesion A Case Report
Gianfranco Spalletta et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2013)
Cisplatin-induced non-apoptotic death of pancreatic cancer cells requires mitochondrial cyclophilin-D-p53 signaling
Bo Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Differential Regulation of Distinct Vps34 Complexes by AMPK in Nutrient Stress and Autophagy
Joungmok Kim et al.
CELL (2013)
Tumor Cell Vasculogenic Mimicry From Controversy to Therapeutic Promise
Richard E. B. Seftor et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Anti-Angiogenic Agents in Pancreatic Cancer: A Review
Murwarid M. Assifi et al.
Anti-Cancer Agents in Medicinal Chemistry (2012)
Cancer treatment and survivorship statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors
Nicola Tinari et al.
CURRENT CANCER DRUG TARGETS (2012)
Perifosine sensitizes curcumin-induced anti-colorectal cancer effects by targeting multiple signaling pathways both in vivo and in vitro
Min-Bin Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Antitumor Activity of Emodin against Pancreatic Cancer Depends on Its Dual Role: Promotion of Apoptosis and Suppression of Angiogenesis
Sheng-Zhang Lin et al.
PLOS ONE (2012)
Targeting Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer - from Molecular Signalling to Clinical Trials
Marco Falasca et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2011)
Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway
Lijun He et al.
CANCER SCIENCE (2011)
Basic and Therapeutic Aspects of Angiogenesis
Michael Potente et al.
CELL (2011)
Tumor angiogenesis: molecular pathways and therapeutic targets
Sara M. Weis et al.
NATURE MEDICINE (2011)
PANCREATIC CANCER IN 2010 New insights for early intervention and detection
Eithne Costello et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer
I. Garrido-Laguna et al.
BRITISH JOURNAL OF CANCER (2010)
Small interfering RNA-directed knockdown of S100A4 decreases proliferation and invasiveness of osteosarcoma cells
Xu Ma et al.
CANCER LETTERS (2010)
MicroRNA-141 Regulates Smad Interacting Protein 1 (SIP1) and Inhibits Migration and Invasion of Colorectal Cancer Cells
Minghua Hu et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Orthogonal use of a human tRNA synthetase active site to achieve multifunctionality
Quansheng Zhou et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively?
Jayaraj Ravindran et al.
AAPS JOURNAL (2009)
Gemcitabine chemoresistance in pancreatic cancer: Molecular mechanisms and potential solutions
Roland Andersson et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes
Jiahao Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Synergic antiproliferative and antiangiogenic effects of EGFR and mTor inhibitors on pancreatic cancer cells
Amalia Azzariti et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors
Baocun Sun et al.
HUMAN PATHOLOGY (2008)
Molecular targeting therapy for pancreatic cancer: current knowledge and perspectives from bench to bedside
Toru Furukawa
JOURNAL OF GASTROENTEROLOGY (2008)
Tumor endothelial cell tube formation model for determining anti-angiogenic activity of a tRNA synthetase cytokine
Quansheng Zhou et al.
METHODS (2008)
Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells
Takashi Kumagai et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Discovery and development of SAHA as an anticancer agent
P. A. Marks
ONCOGENE (2007)
EGFR-mediated expression of aquaporin-3 is involved in human skin fibroblast migration (Publication with Expression of Concern. See vol. 474, pg. 2900, 2017)
Cong Cao et al.
BIOCHEMICAL JOURNAL (2006)
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells
Teru Hideshima et al.
BLOOD (2006)
Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589
DZ Qian et al.
CLINICAL CANCER RESEARCH (2006)
Chemopreventive and therapeutic effects of curcumin
A Duvoix et al.
CANCER LETTERS (2005)
Histone deacetylase inhibitors: from target to clinical trials
WK Kelly et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2002)
Mapping of MST1 kinase sites of phosphorylation - Activation and autophosphorylation
H Glantschnig et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Angiogenesis and vascular architecture in pheochromocytomas - Distinctive traits in malignant tumors
J Favier et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Vasculogenic mimicry and tumor angiogenesis
R Folberg et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
